会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 29. 发明申请
    • MIXED STEROIDAL 1,2,4,5-TETRAOXANE COMPOUNDS AND METHODS OF MAKING AND USING THEREOF
    • 混合固体1,2,4,5-四氯乙烯化合物及其制备和使用方法
    • WO2003068736A2
    • 2003-08-21
    • PCT/US2003/003516
    • 2003-02-07
    • U.S. ARMY MEDICAL RESEARCH AND MATERIAL COMMANDSOLAJA, BogdanMILHOUS, WilburOPSENICA, Dejan, M.POCSFALVI, GabriellaKYLE, Dennis, E.
    • SOLAJA, BogdanMILHOUS, WilburOPSENICA, Dejan, M.POCSFALVI, GabriellaKYLE, Dennis, E.
    • C07D
    • C07J21/00C07J41/0061
    • Disclosed herein are mixed steroidal tetraoxanes having the following structural Formula (I), wherein n is 0, 1, 2, or 3; R is H; ethanoyl, propanoyl, or benzoyl; R1 is H, methyl, ethyl, or isopropyl; R2 is H, methyl, or ethyl; R3 is H, methyl, or ethyl; R4 is H, methyl, ethyl, tert -butyl, phenyl, p -hydroxyphenyl, p -methoxyphenyl, or p -nitrophenyl, or Formula (II), wherein Y is C 1 -C 4 straight or branched-chain alkoxy, or Formula (III), wherein W is N, R5 is hydrogen, methyl, ethyl, or n -propyl, isopropyl, or methyl ethanoate 2-yl, and R6 is hydrogen, methyl, ethyl, or n -propyl, or R5 and R6 are part of a pyrrolidine or piperidine ring; X is a C 1 -C 4 straight or branched-chain alkoxy, a primary amino, a N -akylamino wherein the alkyl is a straight-chain alkyl groups containing from 1 to 4 carbon atoms, methyl ethanoate-2-yl, N -phenylamino, p -nitrophenyl, N , N -dimethylamino, N , N -diethylamino, N , N -di( n -propyl)amino, N -pyrrolidino, or N -piperidino as single compounds, and any mixture of all possible stereoisomers at C(4’’). n may be 0, 1, 2, or 3, and methods of making and using thereof. As disclosed herein, the mixed steroidal tetraoxanes of the present invention exhibit antimalarial, antibacterial, and antiproliferative activity. Thus, as disclosed herein, the mixed steroidal tetraoxanes of the present invention may be used to treat, prevent, or inhibit malaria, bacterial infections, and diseases and disorders associated with cell proliferation in a subject.
    • 本文公开了具有以下结构式I的混合甾族四恶烷,其中n为0,1,2或3 R为H乙酰基,丙酰基或苯甲酰基,R 1为H,甲基,乙基或异丙基,R 2为H,甲基或 乙基R 3为H,甲基或R 4为H,甲基,乙基,叔丁基,苯基,对羟基苯基,对甲氧基苯基或对硝基苯基或式II,其中Y为C 1 -C 4直链或支链, 链烷氧基或式III,其中W是N,R 5是氢,甲基,乙基或正丙基,异丙基或甲基乙酸酯2-基,并且R 6是氢,甲基,乙基或正丙基,或R 5 并且R 6是吡咯烷或哌啶环的一部分,X是C 1 -C 4直链或支链烷氧基,伯氨基,N-烷基氨基,其中烷基是含有1至4个碳原子的直链烷基,甲基 乙酸酯-2-基,N-苯基氨基,对硝基苯基,N,N-二甲基氨基,N,N-二乙基氨基,N,N-二 - 丙基氨基,N-吡咯烷子基或N-哌啶子基作为单一化合物, 所有可能的立体声 在C4“somers。 n可以是0,1,2或3,以及其制备和使用方法。 如本文所公开的,本发明的混合甾族四恶烷显示抗疟疾,抗细菌和抗增殖活性。 因此,如本文所公开的,本发明的混合甾族四恶烷可用于治疗,预防或抑制疟疾,细菌感染以及与受试者中细胞增殖相关的疾病和病症。